| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |